---
title: "BEN-OR URI — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ff47951c-4e7b-5875-a9ab-4e75af6f45ff
json: https://whiteintel.dev/api/public/dossier/ff47951c-4e7b-5875-a9ab-4e75af6f45ff
identifier: sec:0001793464
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BEN-OR URI

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001793464`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ff47951c-4e7b-5875-a9ab-4e75af6f45ff  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ff47951c-4e7b-5875-a9ab-4e75af6f45ff  

## Ownership & control

### Holdings / subsidiaries

- **BIONDVAX PHARMACEUTICALS LTD.** (director) — https://whiteintel.dev/entity/1215b2d5-78a0-5b8e-ba67-3e618c7a43b2
- **BIONDVAX PHARMACEUTICALS LTD.** (officer) — https://whiteintel.dev/entity/1215b2d5-78a0-5b8e-ba67-3e618c7a43b2
- **Nuvectis Pharma, Inc.** (officer) — https://whiteintel.dev/entity/b22d2d51-d8ce-5b5b-bbf2-dea9efa548cb
- **BiomX Inc.** (director) — https://whiteintel.dev/entity/01db328a-2c28-529d-960d-509fc7406f11

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BEN-OR URI**. Human view: https://whiteintel.dev/entity/ff47951c-4e7b-5875-a9ab-4e75af6f45ff · Structured JSON: https://whiteintel.dev/api/public/dossier/ff47951c-4e7b-5875-a9ab-4e75af6f45ff._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._